Máj- és epeúti rák: vizsgálatok itt: Japán
35 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- No phaseTaking peopleAn Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
- Where
- Fukuoka, Kumamoto, Sapporo, Tokushima
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT06342414 - No phaseTaking peopleFirst-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)
- Where
- Chiba, Minato-ku
- Életkor
- 18 év and over
- People
- 200
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07679061 - 1. fázisTaking peopleA Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
- Where
- Chūō, Kashiwa, Niigata, Yokohama
- Életkor
- 2 év and over
- People
- 66
- Run by
- Chiome Bioscience Inc.
See details and how to joinNCT06636435 - No phaseTaking peopleA Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
- Where
- Tokyo
- People
- 60
- Run by
- Eisai Co., Ltd.
See details and how to joinNCT06793709 - No phaseTaking peopleRepeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
- Where
- Aichi, Gifu
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Aichi Medical University
See details and how to joinNCT07235007 - 1/2. fázisTaking peopleA Study of MT-4561 in Patients With Various Advanced Solid Tumors
- Where
- Chuo Ku, City
- Életkor
- 18 év and over
- People
- 27 worldwide
- Run by
- Tanabe Pharma America, Inc.
See details and how to joinNCT06943521 - No phaseNot yet taking people in JapánLTFU for All Cell and Gene Therapy Studies
- Where
- Kashiwa, Kyoto, Osakasayama-shi
- Életkor
- 18 év to 130 év
- People
- 64 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06194461 - No phaseCsak meghívásosInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Tokyo
- Életkor
- 1 nap and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseTaking peopleThe Overall Survival of Patients With Unresectable HCC in Real-life
- Where
- Tokyo
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- Humanity & Health Medical Group Limited
See details and how to joinNCT03612726 - 3. fázisTaking peopleThe ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
- Where
- Hokkaido, Kobe, Kumamoto, Kyoto, Nagasaki, Osaka, Saitama, Toyoake, Ube
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT04803994 · EU 2024-512953-26-00